Clinical evaluation of Apernyl, Alvogyl and Alveospad as a prophylactic measure for dry socket after odontectomy of mandibular molars.
D062365:Aminobenzoates / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004368:Dry Socket / Q000517:prevention & control*; D005054:Eugenol / Q000627:therapeutic use*; D006801:Humans; D006847:Hydrocarbons, Iodinated / Q000627:therapeutic use*; D008334:Mandible; D008963:Molar / Q000601:surgery*; D009822:Oils, Volatile / Q000627:therapeutic use*; D009930:Organic Chemicals; D010226:Parabens / Q000627:therapeutic use*; D014081:Tooth Extraction / Q000009:adverse effects; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D000700:Analgesics; D004338:Drug Combinations; D006847:Hydrocarbons, Iodinated; D009822:Oils, Volatile; D009930:Organic Chemicals; D010226:Parabens; C013804:butyl aminobenzoate, eugenol, iodoform, spearmint oil drug combinations; D062366:para-Aminobenzoates; D005054:Eugenol; C006608:aspirin, 4-hydroxybenzoic acid propyl ester, drug combination; C029875:Alveospad; D001241:Aspirin